Bristol Myers Squibb to buy Turning Point Therapeutics for $4.1B June 6, 2022 Auto Bot News 0 Global pharmaceutical company Bristol Myers Squibb is teed up to acquire Turning Point Therapeutics for $76 per share by the end of Q3.
